RESMED INC — Director's Dealing 2018

Jun 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-06-01

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-01	ResMed Common Stock	F	167	$103.56	Disposed	99083	Direct
2018-06-04	ResMed Common Stock	M	2810	$38.98	Acquired	101893	Direct
2018-06-04	ResMed Common Stock	S	2810	$103.75	Disposed	99083	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-04	ResMed Common Stock Options	$38.98	M	2810	Disposed	2019-11-15	ResMed Common Stock (2810)	Direct

Footnotes

F1: Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted on 06/01/2017.

F2: Includes 145 shares of ResMed stock purchased on April 30, 2018, through the ResMed Employee Stock Purchase Plan.

F3: The transaction was conducted under a Rule 10b5-1 plan.

F4: Represents date options first became exercisable. Options vest 1/3 per year.